MEDIGENE IMMUNOTHERAPIES
Dead / Cancelled — Cancelled — Section 8 (as of 24 Mar 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86605899
- Registration number
- 5038910
- Mark type
- Stylized text
- Filed
- 22 Apr 2015
- Published for opposition
- 28 Jun 2016
- Registered
- 13 Sept 2016
- Attorney of record
- Leonard P. Linardakis
Goods and services
- Class 005 — Pharmaceuticals: Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays for testing of bodily fluids for use in disease detection, namely, tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, all prepared by means of molecular biology, genetic engineering or biotechnological methods; substances for medical diagnosis purposes, namely, proteins, nucleic acids, cell products, protein conjugates, peptides, enzymes and enzyme preparations, particularly antibodies and T cell proteins; T cells, dendritic cells, and other cells of the immune system, viruses, and virus-like particles, all for medical purposes; liposomes for medical purposes; plant extracts for medical purposes; low molecular active ingredients, namely, medicines for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, adjuvants, serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays that test for the presence of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, autoimmune diseases and immune therapy
- Class 042 — Scientific and technological services: Services of a molecular biology or biotechnology laboratory, particularly research and development work in the field of human medical and veterinary medical diagnosis and therapy by means of molecular biology, genetic engineering or biotechnological methods as well as in the field of screening for pharmaceutically active compounds; design and development of test methods and test kits in the field of biotechnology and medicine
- Class 044 — Medical, beauty and agricultural services: Medical analyses and medical consultancy in the context of the treatment of single persons, particularly in the field of tumor precursors, benign and malignant tumor diseases, autoimmune diseases and immunotherapy
- Class 045 — Legal and security services: Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy, and medicine
Owner
- Medigene Immunotherapies GmbH, Planegg/Martinsried, DE
- Medigene Immunotherapies GmbH, Planegg/Martinsried, DE
- Medigene Immunotherapies GmbH, Planegg/Martinsried, DE
Prosecution history
- 24 Mar 2023 — CANCELLED SEC. 8 (6-YR)
- 13 Sept 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Sept 2016 — REGISTERED-PRINCIPAL REGISTER
- 28 Jun 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jun 2016 — PUBLISHED FOR OPPOSITION
- 08 Jun 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 May 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 13 May 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 May 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 May 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 May 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 May 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Dec 2015 — ASSIGNED TO EXAMINER
- 09 Nov 2015 — NOTIFICATION OF NON-FINAL ACTION E-MAILED